Mitochondrial Transcription Factor A added to Osteocytes in a Stressed Environment has a Cytoprotective Effect

Int J Med Sci. 2020 May 23;17(9):1293-1299. doi: 10.7150/ijms.45335. eCollection 2020.

Abstract

The main precipitant of glucocorticoid-associated femoral head osteonecrosis is widely accepted to be an ischemic-hypoxic event, with oxidative stress also as an underlying factor. Mitochondrial DNA is more vulnerable to oxidative injury than the nucleus, and mitochondrial transcription factor A (TFAM), which plays roles in its function, preservation, and regulation is being increasingly investigated. In the present study we focused on the impact of TFAM on the relation between the oxidative injury induced by the addition of glucocorticoid to a hypoxic environment and osteocytic cell necrosis. Using cultured osteocytes MLO-Y4 in a 1% hypoxic environment (hypoxia) to which 1µM dexamethasone (Dex) was added (Dex(+)/hypoxia(+)), an immunocytochemical study was conducted using 8-hydroxy-2'-deoxyguanosine (8-OHdG), an index of oxidative stress, and hypoxia inducible factor-1α (HIF-1α), a marker of hypoxia. Next, after adding TFAM siRNA, TFAM knockdown, cultured for 24h, and mitochondrial membrane potential were measured, they were stained with ATP5A which labels adenosine triphosphate (ATP) production. Dex was added to MLO-Y4 to which TFAM had been added, and cultured for 24h in hypoxia. The ratio of dead cells to viable cells was determined and compared. Enhanced expression of 8-OHdG, HIF-1α was found in osteocytes following the addition of glucocorticoid in a hypoxic environment. With TFAM knockdown, as compared to normoxia, mitochondrial function significantly decreased. On the other hand, by adding TFAM, the incidence of osteocytic cell necrosis was significantly decreased as compared with Dex(+)/hypoxia(+). TFAM was confirmed to be important in mitochondrial function and preservation, inhibition of oxidative injury and maintenance of ATP production. Moreover, prevention of mitochondrial injury can best be achieved by decreasing the development of osteocytic cell necrosis.

Keywords: mitochondrial function; mitochondrial transcription factor A (TFAM); osteocytic cell necrosis; oxidative injury.

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Hypoxia / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • DNA-Binding Proteins / pharmacology*
  • Glucocorticoids / pharmacology
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Membrane Potential, Mitochondrial / drug effects
  • Membrane Potential, Mitochondrial / physiology
  • Mice
  • Mitochondria / drug effects*
  • Mitochondria / metabolism*
  • Mitochondrial Proteins / pharmacology*
  • Mitochondrial Proton-Translocating ATPases / metabolism
  • Necrosis / metabolism
  • Osteocytes / drug effects*
  • Osteocytes / metabolism*
  • Oxidative Stress / drug effects
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Transcription Factors / pharmacology*

Substances

  • DNA-Binding Proteins
  • Glucocorticoids
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Mitochondrial Proteins
  • RNA, Small Interfering
  • Transcription Factors
  • mitochondrial transcription factor A
  • Mitochondrial Proton-Translocating ATPases